What are the recent financial highlights of VARDHMAN HOLDINGS LIMITED?

VARDHMAN HOLDINGS LIMITED recently reported a total revenue of ₹-5.97 Cr and a net profit margin of 0%. These metrics reflect the company’s consistent financial performance.

What is the dividend yield of VARDHMAN HOLDINGS LIMITED?

VARDHMAN HOLDINGS LIMITED offers a dividend yield of 0.14%, with a dividend rate of ₹5.0 per share.

What are the key financial metrics of VARDHMAN HOLDINGS LIMITED?

Key financial metrics include a trailing P/E ratio of 5.070659, forward P/E of , book value of ₹10984.48, price-to-book ratio of 0.30934083, and a market capitalization of ₹10.84 billion.

What does VARDHMAN HOLDINGS LIMITED do?

Vardhman Holdings Limited operates as a non-banking financial company in India. It is involved in investing activities. The company was formerly known as Vardhman Spinning and General Mills Limited and changed its name to Vardhman Holdings Limited in March 2006. Vardhman Holdings Limited was incorporated in 1962 and is based in Ludhiana, India.

Loading...

₹ 0 0.00%

Loading... BSE: Loding... NSE: Vhl

About

Loading... ^[1]

Website BSE NSE

Market Cap ₹ 0 Cr.
Current Price ₹ 0
High / Low ₹ 0 / 0
Stock P/E
Dividend Yield 0 %
ROE 0 %
EPS 0
P/B Ratio 0
Net Profit Margin 0 %
Debt to Equity 0
ROCE 0 %
Interest Coverage 0 %

Stock News - Vhl

Latest updates related to Vhl

Sr No.	Title	Sentiment
1	VHL enhances HDAC6 ubiquitination and inhibits arecoline -induced BMFs... ResearchGate	🔄
2	VHL ameliorates arecoline-induced oral submucosal fibrosis by promoting HDAC6 ubiquitination and blocking NF-κB pathway Nature.com	🔄
3	Impact of Linker Composition on VHL PROTAC Cell Permeability ACS Publications	🔄
4	European Commission Approves Belzutifan for VHL Disease–Associated Tumors, Advanced ccRCC OncLive	🔄
5	Toward a CRISPR-based mouse model of Vhl-deficient clear cell kidney cancer: Initial experience and lessons learned pnas.org	🔄
6	China's NMPA approves MSD’s WELIREG for VHL treatment Pharmaceutical Technology	🔄
7	Merck’s WELIREG® (belzutifan) Approved in China for the Treatment of Adult Patients With Certain Types of Von Hippel-Lindau (VHL) Disease-Associated Tumors Business Wire	🔄
8	Predicting tumor mutation burden and VHL mutation from renal cancer pathology slides with self-supervised deep learning Wiley Online Library	🔄
9	Belzutifan Earns Positive CHMP Opinion for VHL Disease–Associated Tumors, Advanced ccRCC OncLive	🔄
10	Saturation genome editing maps the functional spectrum of pathogenic VHL alleles Nature.com	🔄

Peer Comparison

Macro Industry: Loading.. | Sector: Loading.. | Industry: Loading.. | Basic Industry: Loading..

Loading peers table...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Loading data...

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Loading Profit & Loss data...

Compounded Sales Growth
10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth
10 Years:
5 Years:
3 Years:
TTM:

Stock Price CAGR
10 Years:
5 Years:
3 Years:
1 Year:

Return on Equity
10 Years:
5 Years:
3 Years:
Last Year:

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Shareholding Pattern

Numbers in percentages

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Delivery Data

Insider Data

Technical Data

Static Application Security Testing

Documents

Announcements

Annual reports

Right Issue

Credit ratings

Concalls

Explore More Stocks

TREEHOUSE MMP DATAPATTNS LCCINFOTEC FINCABLES NAVA FELIX MSTCLTD VGUARD PREMIERPOL